ArticleJMIR diabetes2019
The Effect of a Cellular-Enabled Glucose Meter on Glucose Control for Patients With Diabetes: Prospective Pre-Post Study.
Article in JMIR diabetes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- The Management Perspective in Digital Health Literature: Systematic Review.JMIR mHealth and uHealth · 2022Pooled it
- The Impact of Digital Self-Monitoring of Weight on Improving Diabetes Clinical Outcomes: Quasi-Randomized Study.Journal of medical Internet research · 2024Trial
- Remote glucose monitoring is feasible for patients and providers using a commercially available population health platform.Frontiers in endocrinology · 2023Trial
- Machine learning and engagement insights for personalized blood glucose management.Frontiers in digital health · 2026Article
- Pregestational Diabetes Intervention Pilot Study With Diabetes Self-Management Education and Support and Cellular-Enabled Glucose Meter.Diabetes spectrum : a publication of the American Diabetes Association · 2025Article
- Adoption of Digital Therapeutics in Europe.Therapeutics and clinical risk management · 2024Review
- Beyond the EHR: How Digital Health Tools Foster Participatory Health and Self-Care for Patients with Diabetes.American journal of medicine open · 2023Article
- Blood Pressure Monitoring as a Digital Health Tool for Improving Diabetes Clinical Outcomes: Retrospective Real-world Study.Journal of medical Internet research · 2022Article
- Efficacy of Digitally Supported and Real-Time Self-Monitoring of Blood Glucose-Driven Counseling in Patients with Type 2 Diabetes Mellitus: A Real-World, Retrospective Study in North India.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022Article
- Telemedicine via Continuous Remote Care: A Proactive, Patient-Centered Approach to Improve Clinical Outcomes.JMIR diabetes · 2021Article
- Change in Glycemic Control for Patients Enrolled in a Membership-Based Primary Care Program: Longitudinal Observational Study.JMIR diabetes · 2021Article
- Remote patient monitoring sustains reductions of hemoglobin A1c in underserved patients to 12 months.Primary care diabetes · 2021Article
- Role of Digital Engagement in Diabetes Care Beyond Measurement: Retrospective Cohort Study.JMIR diabetes · 2021Article
- Real-world insights from launching remote peer-to-peer mentoring in a safety net healthcare delivery setting.Journal of the American Medical Informatics Association : JAMIA · 2021Article
- Digital Diabetes Care System Observations from a Pilot Evaluation Study in Vietnam.International journal of environmental research and public health · 2020Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes is a global epidemic affecting approximately 30 million people in the United States. The World Health Organization recommends using technology and telecommunications to improve health care delivery and disease management. The Livongo for Diabetes Program offers a remote monitoring technology with Certified Diabetes Educator outreach.
objectiveThe purpose of this study was to examine health outcomes measured by changes in HbA
methodsThe impact of the Livongo for Diabetes program on hemoglobin A
resultsA total of 86 adults were enrolled into the Livongo for Diabetes program, with 49% (42/86) female, an average age of 50 (SD 15) years, 56% (48/86) with type 2 diabetes mellitus, and 69% (59/86) with insulin use. The mean HbA
conclusionsParticipants provided with a cellular-enabled blood glucose meter with real-time feedback and access to coaching from a certified diabetes educator in an outpatient clinical setting experienced improved mean glucose values and fewer episodes of hypoglycemia relative to the start of the program.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.